查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370315

流式細胞儀市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Flow Cytometry Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

概要

市場概況：

2022年全球流式細胞儀市場規模達54億美元。展望未來，IMARC Group預計到2028年市場規模將達到86億美元，2023-2028年年複合成長率（CAGR）為8.1%。個人化醫療產品的廣泛採用、生命科學和生物技術研究活動的擴大以及對學術和研究機構的資助不斷增加是推動市場的一些主要因素。

流式細胞儀是一種可以對異質群體中的單一細胞進行詳細多參數分析的技術。該技術使用光來檢測和測量細胞或顆粒群的物理和化學特性。每個顆粒懸浮在流體流中並通過電子檢測裝置。將一束光射到流上，光散射是粒子及其特性的特徵。這些模式的強度可用於導出有關每個細胞的物理和化學結構的各種類型的資料。這些資訊在診斷和生物醫學研究等廣泛應用中都很有價值。它可以每秒快速分析數千個粒子，並同時收集有關單一細胞的多個參數的資料。因此，它是細胞生物學和醫學的重要工具。

生命科學和生物技術研究活動的擴展主要推動全球市場。它是細胞生物學、免疫學和腫瘤學研究的重要工具。它廣泛用於細胞週期和增殖、凋亡和其他細胞功能的研究。這些研究領域（尤其是發展中國家）的投資不斷增加，影響了對這些儀器、試劑和軟體的需求。此外，這些方法在疾病檢測和監測方面的精確度和效率使其成為個人化醫療的理想選擇。隨著這種醫療模式的採用率不斷上升，它正在顯著推動市場的成長。除此之外，學術和研究機構，特別是從事細胞研究的學術和研究機構的資金不斷增加，一直是市場的重要推動力。這些資金有助於購買先進的細胞計數技術和新應用的開發，並推動整體市場的成長。此外，人們越來越意識到早期診斷和治療的好處，加上中產階級人口的不斷成長，正在創造積極的市場前景。

流式細胞儀市場趨勢/促進因素：

慢性病盛行率增加

癌症、愛滋病毒/愛滋病和其他免疫系統相關疾病等慢性病發病率的上升極大地推動了對流式細胞儀的需求。除此之外，流式細胞儀在幾种血液惡性腫瘤的診斷和預後中不可或缺，並且擴大用於監測疾病進展和治療反應。隨著全球人口老化和此類疾病的盛行率增加，對快速、準確的診斷和監測工具的需求也在增加。因此，醫療保健產業不斷努力提供有效的治療和改善患者的生活品質，成為流式細胞儀市場的重要驅動力。

增加臨床試驗和藥物發現的採用

該方法在臨床試驗和藥物發現中的廣泛採用是一個重要的市場驅動力。此外，流式細胞儀能夠提供有關單一細胞和細胞群的詳細資訊，使其成為評估藥物效果和識別潛在治療靶點的理想選擇。除此之外，製藥公司越來越依賴這些方法進行臨床前測試和臨床試驗，以評估新藥的安全性和有效性。因此，它對市場產生正面影響。隨著製藥業的不斷擴大和新藥候選數量的不斷增加，該領域對流式細胞儀的需求大幅加速，推動了市場的整體成長。

持續的技術進步

流式細胞儀產業的主要市場驅動力之一是該領域的持續技術進步。高通量流式細胞儀的出現、提供更好資料分析的軟體解決方案的進步以及特定探針和試劑的開發顯著提高了流式細胞儀的功效。此外，緊湊、方便用戶使用且價格實惠的系統的引入導致了該技術的民主化，將其用途從研究實驗室擴展到臨床環境，甚至床邊診斷。多色檢測和試劑也增加，可以同時檢測許多參數，進一步增強了能力。這些進步不僅提供了更有效率、更可靠的結果，而且擴大了潛在應用範圍，從而促進了市場的成長。

流式細胞儀產業細分：

IMARC Group 提供了全球流式細胞儀市場報告各細分市場主要趨勢的分析，以及 2023-2028 年全球、區域和國家層面的預測。我們的報告根據產品和服務、技術、應用和最終用戶對市場進行了分類。

按產品和服務細分：

儀器

試劑及耗材

配件

軟體

服務

儀器儀表主導市場

該報告根據產品和服務對市場進行了詳細的細分和分析。這包括儀器、試劑和消耗品、配件、軟體和服務。報告稱，儀器儀表佔最大部分。

在該行業中，儀器和服務的市場促進因素是多方面的。隨著儀器變得更加精確、方便用戶使用且價格實惠，它們促進了應用範圍的擴大，從而推動了需求。此外，攜帶式和台式流式細胞儀的發展使該技術更容易獲得，從而促進了這些儀器的銷售。由於流式細胞儀在各個領域的使用不斷增加，與流式細胞儀相關的服務（例如維護、培訓和資料分析）的需求也不斷增加。方法資料的複雜性需要專門的軟體和熟練的專業人員進行分析，因此這些服務至關重要。隨著越來越多的企業和研究機構採用流式細胞儀，他們經常尋求這些服務以確保有效的操作和準確的​​結果，從而進一步推動這些服務的市場。

按技術分類：

基於細胞的流式細胞儀

基於珠的流式細胞儀

基於細胞的流式細胞儀主導市場

報告還提供了基於該技術的詳細市場細分和分析。這包括基於細胞的流式細胞儀和基於珠的流式細胞術。根據該報告，基於細胞的流式細胞儀代表了最大的部分。

該行業中基於細胞的技術市場是由癌症等疾病發病率不斷增加所推動的，在癌症的診斷和監測中發揮關鍵作用。該技術提供了有關細胞特徵和行為的寶貴資訊，對於了解疾病進展和治療反應至關重要。此外，包括幹細胞研究和細胞治療在內的細胞研究的進步，對市場成長做出了重大貢獻。這些領域需要深入的細胞分析，而流式細胞儀是滿足這些需求的關鍵工具。此外，對個人化醫療日益成長的興趣是另一個促進因素，個人化醫療需要細胞層面的精確資訊來制定個人化治療策略。此外，基因組學和蛋白​​質組學中單細胞分析的興起正在增加對基於細胞的流式細胞儀的需求，因為它能夠分析群體中的單一細胞。

按應用分類：

腫瘤學

藥物發現

疾病診斷

幹細胞治療

器官移植

血液學

其他

腫瘤學佔市場主導地位

該報告根據應用程式提供了詳細的市場細分和分析。這包括腫瘤學、藥物發現、疾病診斷、幹細胞治療、器官移植、血液學等。根據該報告，腫瘤學佔最大的部分。

腫瘤學領域的市場很大程度上是由全球癌症發生率上升以及該方法在癌症研究和患者管理中不可或缺的作用所推動的。流式細胞儀可對細胞群進行快速、詳細的分析，對於診斷各種形式的癌症，特別是血液惡性腫瘤至關重要。它也廣泛用於監測疾病進展和治療反應，從而有助於癌症管理的決策過程。同時，腫瘤學中個人化醫療的不斷採用，需要高解析度細胞分析來制定量身定做的治療策略，進一步推動了對流式細胞儀的需求。此外，流式細胞儀技術的進步，例如多色流式細胞儀的發展，顯著增強了其在癌症研究方面的能力。

按最終用戶分類：

醫院和診所

學術及研究機構

製藥和生物技術公司

其他

醫院和診所主導市場

報告還提供了基於最終用戶的詳細市場細分和分析。這包括醫院和診所、學術和研究機構、製藥和生物技術公司等。根據該報告，以細胞為基礎的醫院和診所代表了最大的部分。

醫院和診所內的市場是由需要流式細胞儀進行診斷和監測的疾病（例如癌症和免疫性疾病）日益流行所推動的。隨著這些疾病的患者負荷增加，這些醫療保健環境中對快速、準確的診斷工具的需求也隨之增加。此外，技術進步帶來了更緊湊和方便用戶使用的流式細胞儀，使醫院和診所更容易採用該技術。個人化醫療的興起也促進了流式細胞儀在這些環境中的使用，因為它提供了個人化治療策略所需的詳細細胞分析。此外，隨著這種方法因其提供快速、全面結果的能力而得到越來越多的認可，保險公司擴大涵蓋基於流式細胞儀的測試，進一步促進其在醫院和診所的採用。

按地區分類：

北美洲

美國

加拿大

亞太地區

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美表現出明顯的主導地位，佔據最大的流式細胞儀市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美佔據最大的市場佔有率。

北美流式細胞儀產業的成長是由完善的醫療基礎設施和強大的研究環境所推動的，這兩者都促進了先進技術的採用和開發。除此之外，癌症等慢性疾病的高發生率也促進了市場的成長，這種方法在診斷和監測中發揮著至關重要的作用。此外，該地區領先公司的存在支持創新技術和應用的開發。此外，對研發的大量投資，包括廣泛使用流式細胞儀的生物醫學研究、臨床試驗和藥物發現過程，進一步推動了市場成長。該地區對個人化醫療的興趣日益濃厚，需要流式細胞儀提供詳細的細胞分析，這也促進了市場需求。

競爭格局：

由於對先進流式細胞儀技術的研發投資不斷增加，全球流式細胞儀市場正經歷顯著成長。這包括開發新儀器、試劑、軟體和方法。這些進步旨在增強流式細胞儀的功能，使其更加精確、高效和方便用戶使用。同時，與其他企業、研究機構和醫療保健提供者的策略合作夥伴關係的不斷增加也極大地支持了市場。這些合作通常旨在推動研究、開發新應用並擴大流式細胞儀技術的範圍。除此之外，製造商還推出教育和培訓服務，例如研討會、網路研討會或線上教程，以幫助用戶在工作中充分利用流式細胞儀的潛力。因此，它對市場有很大的支撐。此外，主要參與者正在提供強大的客戶服務和技術支持，這正在創造積極的市場前景。

該報告對全球流式細胞儀市場的競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

安捷倫科技公司

Apogee Flow 系統有限公司

BD（貝克頓迪金森公司）

貝克曼庫爾特公司（丹納赫公司）

Bio-RAD 實驗室公司

恩佐生命科學公司

魯米奈克斯公司

默克公司

索尼生技公司

希森美康帕泰克有限公司

賽默飛世爾科技公司

最近的發展：

2023 年 2 月，安捷倫科技公司宣布推出新的 NovoExpress 軟體，該軟體為 NovoCyte 流式細胞儀設備帶來了整合合規性工具。

2023 年6 月，BD（Becton、Dickinson and Company）宣佈在全球商業推出一款新型自動化設備，該設備可使用流式細胞儀清潔臨床診斷樣品，提供完整的「無人值守」工作流程解決方案，旨在提高細胞診斷的標準化和可重複性。

2021 年 6 月，Bio-RAD Laboratories Inc. 發布了三種用於流式細胞儀的 StarBright 染料。 StarBright Violet 570、670 和 710 染料適用於多色流式細胞儀面板，因為它們具有增強的亮度以及準確的激發和發射光譜。

本報告回答的關鍵問題

  • 2022年全球流式細胞儀市場規模是多少
  • 2023-2028年全球流式細胞儀市場的預期成長率是多少
  • 推動全球流式細胞儀市場的關鍵因素是什麼
  • COVID-19 對全球流式細胞儀市場有何影響
  • 基於產品和服務的全球流式細胞儀市場的細分是什麼
  • 基於該技術的全球流式細胞儀市場的詳細情形如何
  • 基於應用的全球流式細胞儀市場區隔是怎樣的
  • 基於最終用戶的全球流式細胞儀市場的細分是什麼
  • 全球流式細胞儀市場的重點區域有哪些
  • 10. 全球流式細胞儀市場的主要參與者/公司有哪些？

本報告回答的關鍵問題

  • 2022年全球流式細胞儀市場規模有多大？
  • 2023-2028年全球流式細胞儀市場的預期成長率是多少？
  • 推動全球流式細胞儀市場的關鍵因素是什麼？
  • COVID-19 對全球流式細胞儀市場有何影響？
  • 根據產品和服務，全球流式細胞儀市場的詳細情形如何？
  • 基於該技術的全球流式細胞儀市場的詳細情形如何？
  • 基於應用的全球流式細胞儀市場的詳細情形如何？
  • 根據最終用戶，全球流式細胞儀市場的詳細情形如何？
  • 全球流式細胞儀市場的關鍵區域有哪些？
  • 全球流式細胞儀市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球流式細胞儀市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按產品和服務分類的市場

  • 儀器
    • 市場走向
    • 市場預測
  • 試劑及耗材
    • 市場走向
    • 市場預測
  • 配件
    • 市場走向
    • 市場預測
  • 軟體
    • 市場走向
    • 市場預測
  • 服務
    • 市場走向
    • 市場預測

第 7 章：依科技分類的市場

  • 基於細胞的流式細胞儀
    • 市場走向
    • 市場預測
  • 基於珠的流式細胞儀
    • 市場走向
    • 市場預測

第 8 章：按應用分類的市場區隔

  • 腫瘤學
    • 市場走向
    • 市場預測
  • 藥物發現
    • 市場走向
    • 市場預測
  • 疾病診斷
    • 市場走向
    • 市場預測
  • 幹細胞治療
    • 市場走向
    • 市場預測
  • 器官移植
    • 市場走向
    • 市場預測
  • 血液學
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：最終用戶的市場區隔

  • 醫院和診所
    • 市場走向
    • 市場預測
  • 學術及研究機構
    • 市場走向
    • 市場預測
  • 製藥和生物技術公司
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Apogee Flow Systems Ltd.
    • BD (Becton, Dickinson and Company)
    • Beckman Coulter Inc. (Danaher Corporation)
    • Bio-RAD Laboratories Inc.
    • Enzo Life Sciences Inc.
    • Luminex Corporation
    • Merck KGaA
    • Sony Biotechnology Inc.
    • Sysmex Partec GmbH
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A2272

Abstract

Market Overview:

The global flow cytometry market size reached US$ 5.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028. The widespread product adoption in personalized medicine, the expansion of research activities in life sciences and biotechnology, and the accelerating funding for academic and research institutes are some of the major factors propelling the market.

Flow cytometry is a technology that allows detailed multi-parameter analysis of individual cells within a heterogeneous population. This technique uses light to detect and measure physical and chemical properties of a population of cells or particles. Each particle is suspended in a stream of fluid and passed through an electronic detection apparatus. A beam of light is directed onto the stream, and the light scatter is characteristic of the particles and their properties. The intensity of these patterns can be used to derive various types of data about the physical and chemical structure of each cell. This information is valuable in a wide range of applications, including diagnostics and biomedical research. It can quickly analyze thousands of particles per second and concurrently gather data about multiple parameters of a single cell. Therefore, it is an essential tool in cell biology and medicine.

The expansion of research activities in life sciences and biotechnology majorly drives the global market. It is a crucial tool in cell biology, immunology, and oncology research. It is extensively used in the study of cell cycle and proliferation, apoptosis, and other cellular functions. The rising investments in these research areas, especially in developing countries, have influenced the demand for these instruments, reagents, and software. In addition, the precision and efficiency of these method in the detection and monitoring of diseases make it ideal for personalized medicine. As this medical model continues to rise in adoption, it is significantly driving the growth of the market. Apart from this, the accelerating funding for academic and research institutes, particularly those engaged in cell-based research, has been a considerable driver for the market. These funds facilitate the purchase of advanced cytometry technologies and the development of new applications, driving the overall market growth. Moreover, the accelerating awareness about the benefits of early diagnosis and therapeutics, coupled with a growing middle-class population is creating a positive market outlook.

Flow Cytometry Market Trends/Drivers:

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases such as cancer, HIV/AIDS, and other immune system-related diseases has substantially driven the demand for flow cytometry. Along with this, flow cytometry is indispensable in the diagnosis and prognosis of several hematological malignancies and is increasingly being used in monitoring disease progression and treatment response. As the global population ages and the prevalence of such diseases increases, the need for fast, accurate diagnostic and monitoring tools also grows. Consequently, the healthcare sector's ongoing efforts to provide effective treatments and improve patients' quality of life act as a significant driving force for the flow cytometry market.

Increased Adoption in Clinical Trials and Drug Discovery

The widespread adoption of the method in clinical trials and drug discovery is a significant market driver. In addition, flow cytometry's ability to provide detailed information about individual cells and cellular populations makes it ideal for evaluating drug effects and identifying potential therapeutic targets. Apart from this, pharmaceutical companies are increasingly relying on these methods for preclinical testing and clinical trials to assess the safety and efficacy of new drugs. Therefore, it is positively influencing the market. With the expanding pharmaceutical industry and escalating number of new drug candidates, the demand for flow cytometry in this domain is accelerating substantially, driving the overall growth of the market.

Continuous Technological Advancements

One of the primary market drivers for the flow cytometry industry is the continued technological advancements in this field. The emergence of high-throughput flow cytometry, advancement in software solutions that offer better data analysis, and development of specific probes and reagents have significantly improved the efficacy of flow cytometry. Additionally, the introduction of compact, user-friendly, and affordable systems has led to the democratization of this technology, expanding its use from research labs to clinical settings and even point-of-care diagnostics. There has also been a rise in multicolor assays and reagents which allow simultaneous detection of many parameters, further enhancing the capabilities. These advancements not only provide more efficient and reliable results but also widen the range of potential applications, thereby contributing to the growth of the market.

Flow Cytometry Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global flow cytometry market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product and service, technology, application and end-user.

Breakup by Product and Service:

Instruments

Reagents and Consumables

Accessories

Software

Services

Instruments dominate the market

The report has provided a detailed breakup and analysis of the market based on the product and service. This includes instruments, reagents and consumables, accessories, software, and services. According to the report, instruments represented the largest segment.

In the industry, market drivers for instruments and services are multifaceted. As instruments become more precise, user-friendly, and affordable, they facilitate an expanded range of applications, thus driving demand. In addition, the development of portable and benchtop flow cytometers has made the technology more accessible, boosting the sales of these instruments. Services related to flow cytometry, such as maintenance, training, and data analysis, also experience increased demand driven by the growing usage of this method in various sectors. The complexity of the method data requires specialized software and skilled professionals for analysis, making these services critical. As more businesses and research institutions adopt flow cytometry, they often seek out these services to ensure effective operation and accurate results, further propelling the market for these services.

Breakup by Technology:

Cell-Based Flow Cytometry

Bead-Based Flow Cytometry

Cell-based flow cytometry dominates the market

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes cell-based flow cytometry and bead-based flow cytometry. According to the report, cell-based flow cytometry represented the largest segment.

The market for cell-based technology in the industry is driven by the increasing incidence of diseases such as cancer, where it plays a critical role in diagnosis and monitoring. This technology provides valuable information about cellular characteristics and behavior, making it crucial for understanding disease progression and treatment response. In addition, advancements in cell-based research, including stem cell research and cell therapeutics, contribute significantly to the market growth. These fields require in-depth cellular analysis, and flow cytometry is a key tool to meet these needs. In addition, the growing interest in personalized medicine, which requires precise information at the cellular level to develop individualized treatment strategies, is another driving factor. Moreover, the rise of single-cell analysis in genomics and proteomics is boosting the demand for cell-based flow cytometry, given its capability to analyze individual cells within a population.

Breakup by Application:

Oncology

Drug Discovery

Disease Diagnosis

Stem Cell Therapy

Organ Transplantation

Hematology

Others

Oncology dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes oncology, drug discovery, disease diagnosis, stem cell therapy, organ transplantation, hematology, and others. According to the report, oncology represented the largest segment.

The market in the field of oncology is largely driven by the rising global incidence of cancer and the indispensable role of this method in cancer research and patient management. Flow cytometry provides rapid, detailed analysis of cell populations, making it essential for diagnosing various forms of cancer, particularly hematological malignancies. It is also widely used for monitoring disease progression and response to treatment, thereby contributing to the decision-making process in cancer management. In confluence with this, the esclating adoption of personalized medicine in oncology, which requires high-resolution cellular analysis to develop tailored treatment strategies, further propels the demand for flow cytometry. Additionally, advancements in flow cytometry technology, such as the development of multicolor flow cytometry, have significantly enhanced its capabilities in cancer research.

Breakup by End-User:

Hospitals and Clinics

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Others

Hospitals and clinics dominate the market

A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes hospitals and clinics, academic and research institutes, pharmaceutical and biotechnology companies, and others. According to the report, cell-based hospitals and clinics represented the largest segment.

The market within hospitals and clinics is being driven by the growing prevalence of diseases that require flow cytometry for diagnosis and monitoring, such as cancers and immunological disorders. As the patient load for these conditions grows, so does the need for rapid, accurate diagnostic tools in these healthcare settings. Moreover, technological advancements have resulted in more compact and user-friendly flow cytometers, making it easier for hospitals and clinics to adopt this technology. The rise of personalized medicine also promotes the use of flow cytometry in these settings, as it provides the detailed cellular analysis needed for personalized treatment strategies. In addition, as this method becomes more recognized for its ability to deliver fast and comprehensive results, insurance providers are increasingly covering flow cytometry-based tests, further promoting its adoption in hospitals and clinics.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest flow cytometry market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The growth of the flow cytometry industry in North America is driven by a well-established healthcare infrastructure and robust research environment, both of which foster the adoption and development of advanced technologies. Along with this, the high incidence of chronic diseases such as cancer, where this method plays a crucial role in diagnosis and monitoring, also contributes to market growth. Additionally, the presence of leading companies in this region supports the development of innovative technologies and applications. Furthermore, the significant investment in research and development, including biomedical research, clinical trials, and drug discovery processes that extensively use flow cytometry, further fuels market growth. The region's growing interest in personalized medicine, which requires detailed cellular analysis provided by flow cytometry, also contributes to the market demand.

Competitive Landscape:

The global flow cytometry market is experiencing significant growth due to the growing investments in research and development to create advanced flow cytometry technologies. This includes the development of new instruments, reagents, software, and methodologies. These advancements aim to enhance the capabilities of flow cytometry, making it more precise, efficient, and user-friendly. Along with this, the escalating number of strategic partnerships with other businesses, research institutions, and healthcare providers is significantly supporting the market. These collaborations often aim to advance research, develop new applications, and broaden the reach of flow cytometry technology. Apart from this, the manufacturers are introducing education and training services, such as workshops, webinars, or online tutorials to help users fully utilize the potential of flow cytometry in their work. Therefore, it is significantly supporting the market. Moreover, key players are providing strong customer service and technical support, which is creating a positive market outlook.

The report has provided a comprehensive analysis of the competitive landscape in the global flow cytometry market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.

Apogee Flow Systems Ltd.

BD (Becton, Dickinson and Company)

Beckman Coulter Inc. (Danaher Corporation)

Bio-RAD Laboratories Inc.

Enzo Life Sciences Inc.

Luminex Corporation

Merck KGaA

Sony Biotechnology Inc.

Sysmex Partec GmbH

Thermo Fisher Scientific Inc.

Recent Developments:

In February 2023, Agilent Technologies Inc. announced the availability of new NovoExpress software, which brings integrated compliance tools for NovoCyte flow cytometer devices.

In June 2023, BD (Becton, Dickinson and Company) announced the global commercial launch of a new automated device that cleans samples for clinical diagnostics using flow cytometry, offering a full "walkaway" workflow solution intended to increase standardisation and repeatability in cellular diagnostics.

In June 2021, Bio-RAD Laboratories Inc. released three StarBright Dyes made for use in flow cytometry. StarBright Violet 570, 670, and 710 Dyes are appropriate for use in multicolor flow cytometry panels because to their enhanced brightness and accurate excitation and emission spectra.

Key Questions Answered in This Report

  • 1. What was the size of the global flow cytometry market in 2022?
  • 2. What is the expected growth rate of the global flow cytometry market during 2023-2028?
  • 3. What are the key factors driving the global flow cytometry market?
  • 4. What has been the impact of COVID-19 on the global flow cytometry market?
  • 5. What is the breakup of the global flow cytometry market based on the product and service?
  • 6. What is the breakup of the global flow cytometry market based on the technology?
  • 7. What is the breakup of the global flow cytometry market based on the application?
  • 8. What is the breakup of the global flow cytometry market based on the end-user?
  • 9. What are the key regions in the global flow cytometry market?
  • 10. Who are the key players/companies in the global flow cytometry market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Flow Cytometry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Accessories
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Software
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Services
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Cell-Based Flow Cytometry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bead-Based Flow Cytometry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Discovery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Disease Diagnosis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Stem Cell Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Organ Transplantation
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Hematology
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Apogee Flow Systems Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 BD (Becton, Dickinson and Company)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Bio-RAD Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Enzo Life Sciences Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Luminex Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sony Biotechnology Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sysmex Partec GmbH
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Flow Cytometry Market: Major Drivers and Challenges
  • Figure 2: Global: Flow Cytometry Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Flow Cytometry Market: Breakup by Product and Service (in %), 2022
  • Figure 4: Global: Flow Cytometry Market: Breakup by Technology (in %), 2022
  • Figure 5: Global: Flow Cytometry Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Flow Cytometry Market: Breakup by End-User (in %), 2022
  • Figure 7: Global: Flow Cytometry Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Flow Cytometry Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 9: Global: Flow Cytometry (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Flow Cytometry (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Flow Cytometry (Reagents and Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Flow Cytometry (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Flow Cytometry (Accessories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Flow Cytometry (Accessories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Flow Cytometry (Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Flow Cytometry (Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Flow Cytometry (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Flow Cytometry (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Flow Cytometry (Cell-Based) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Flow Cytometry (Cell-Based) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Flow Cytometry (Bead-Based) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Flow Cytometry (Bead-Based) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Flow Cytometry (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Flow Cytometry (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Flow Cytometry (Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Flow Cytometry (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Flow Cytometry (Disease Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Flow Cytometry (Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Flow Cytometry (Stem Cell Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Flow Cytometry (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Flow Cytometry (Organ Transplantation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Flow Cytometry (Organ Transplantation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Flow Cytometry (Hematology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Flow Cytometry (Hematology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Flow Cytometry (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Flow Cytometry (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Flow Cytometry (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Flow Cytometry (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Flow Cytometry (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Flow Cytometry (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Flow Cytometry (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Flow Cytometry (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Flow Cytometry (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Flow Cytometry (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: North America: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: North America: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: United States: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: United States: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Canada: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Canada: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Asia Pacific: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Asia Pacific: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: China: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: China: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Japan: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Japan: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: India: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: India: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: South Korea: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: South Korea: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Australia: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Australia: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Indonesia: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Indonesia: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Others: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Others: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Europe: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Europe: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Germany: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Germany: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: France: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: France: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: United Kingdom: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: United Kingdom: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Italy: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Italy: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Spain: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Spain: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Russia: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Russia: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Latin America: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Latin America: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Brazil: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Brazil: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Mexico: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Mexico: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Others: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Others: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Middle East and Africa: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Middle East and Africa: Flow Cytometry Market: Breakup by Country (in %), 2022
  • Figure 93: Middle East and Africa: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 94: Global: Flow Cytometry Industry: SWOT Analysis
  • Figure 95: Global: Flow Cytometry Industry: Value Chain Analysis
  • Figure 96: Global: Flow Cytometry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Flow Cytometry Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Flow Cytometry Market Forecast: Breakup by Product and Service (in Million US$), 2023-2028
  • Table 3: Global: Flow Cytometry Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Flow Cytometry Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Flow Cytometry Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 6: Global: Flow Cytometry Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Flow Cytometry Market: Competitive Structure
  • Table 8: Global: Flow Cytometry Market: Key Players